Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063517 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Bistra Galunska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria. Hauptthemen laut MEDLINE: Vascular Calcification, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, National Recovery and Resilience Plan of the Republic of Bulgaria, European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria.
Abstract (Originalsprache)
One mechanism to regulate pathological vascular calcification (VC) is its active inhibition. Loss or inactivation of endogenic inhibitors is a major inductor of VC. Such inhibitors are proteins rich in gamma-glutamyl residues (Gla-proteins), whose function strongly depends on vitamin K. The current narrative review is focused on discussing the role of extrahepatic vitamin K-dependent Gla-proteins (osteocalcin, OC; matrix Gla-protein, MGP; Gla-rich protein, GRP) in cardio-vascular pathology. Gla-proteins possess several functionally active forms whose role in the pathogenesis of VC is still unclear. It is assumed that low circulating non-phosphorylated MGP is an indicator of active calcification and could be a novel biomarker of prevalent VC. High circulating completely inactive MGP is proposed as a novel risk factor for cardio-vascular events, disease progression, mortality, and vitamin K deficiency. The ratio between uncarboxylated (ucOC) and carboxylated (cOC) OC is considered as an indicator of vitamin K status indirectly reflecting arterial calcium. Despite the evidence that OC is an important energy metabolic regulator, its role on global cardio-vascular risk remains unclear. GRP acts as a molecular mediator between inflammation and calcification and may emerge as a novel biomarker playing a key role in these processes. Gla-proteins benefit clinical practice as inhibitors of VC, modifiable by dietary factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.
- First Department of Internal Diseases, Section Cardiology, Medical University of Varna, 9000 Varna, Bulgaria.
- Second Cardiology Clinic, Department of Non-Invasive Cardiology, University Hospital "St. Marina", 9000 Varna, Bulgaria.
- First Cardiology Clinic with Intensive Cardiology Activity, University Hospital "St. Marina", 9000 Varna, Bulgaria.
ORCID-Profile: Yoto Yotov
Förderung
- European Union-NextGenerationEU, National Recovery and Resilience Plan of the Republic of Bulgaria
- European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
Zitieren
APA
Galunska, B., Yotov, Y., Nikolova, M., & Angelov, A. (2024). Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063517
Vancouver
Galunska B, Yotov Y, Nikolova M, Angelov A. Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063517
BibTeX
@article{Galunska2024,
author = {Galunska, Bistra and Yotov, Yoto and Nikolova, Miglena and Angelov, Atanas},
title = {Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063517}
}
EUVIMED